CLA Reports Reviewed at NIH Conference

CLA Reports Reviewed at NIH Conference

BETHESDA, Md.--According to Natural Inc., supplierof Tonalin CLA, several studies about the benefits of conjugated linoleic acid(CLA) were reviewed by scientists during a National Institutes of Health (NIH)conference held here in mid-May. The review covered studies on CLA's efficacyfor cancer, immune function, cardiovascular disease, diabetes and osteoporosis.

"The recent global CLA research ... is exciting as itdemonstrates the potential multiple health benefits related to CLAsupplementation," Delbert Dorscheid, M.D., assistant professor of medicineat the University of British Columbia, said at the event. "In particular,the work on glucose control, artheosclerosis, blood lipids and control of asthmaand allergies appears to hold near term promise."